Why Solvay (ENXTBR:SOLB) Is Back In The Spotlight

Solvay (ENXTBR:SOLB) just packed several signals into one update: third quarter results, a stable interim dividend of €0.97 per share, and a long-term rare earths feedstock agreement all landed together.

Recent trading tells a mixed story for Solvay. The 7 day share price return of 3.02% and 1 day gain of 1.15% contrast with a 90 day share price decline of 8.36% and year to date drop of 10.24%. At the same time, the 3 year total shareholder return of 48.63% and 5 year total shareholder return of 46.90% point to stronger performance over a longer horizon.

Scan how other dividend payers and materials stocks are reacting to similar pressures by reviewing our hand picked 211 high quality undervalued stocks, which combines income, balance sheet strength, and potential mispricing.

Solvay shares now trade at a sizeable discount to one fair value estimate while sitting slightly above the average analyst target. Is that a mispriced opportunity or a warning that the market has been right so far?

Most Popular Narrative: 90% Undervalued

The most followed narrative sees Solvay's fair value at €24.77, almost exactly in line with the recent price, yet a separate cash flow estimate of €37.23 suggests a deeper gap between market pricing and longer term potential. That split view puts real weight on the company actually delivering on its transformation and rare earth plans.

Expansion of Solvay's rare earth activities, including the planned €15 to €20m investment to add heavy rare earth separation capacity in France by fall 2026 and the Brazilian feedstock agreement starting 2028, supports the build out of a higher margin revenue stream that is already about 8% of group sales and can have an outsized impact on group EBITDA contribution.

See why 32 investors see Solvay as 1% undervalued.

Result: Fair Value of €24.77 (UNDERVALUED)

Still, pressure on soda ash pricing and the ongoing hit from the Saudi peroxide shutdown could quickly challenge the Solvay transformation story that investors are leaning on.

Find out about the key risks to this Solvay narrative.

Another View on Solvay’s Valuation

The earlier fair value of €24.77 comes from a cash flow driven view that flags Solvay as undervalued, with the shares trading around €24.54 and a separate SWS DCF model output of €37.23 pointing to a much higher figure.

That gap is large. It suggests the cash flow model assumes Solvay successfully converts its rare earth plans, cost savings and earnings recovery into stronger long term cash generation than the current share price reflects. The question for you is simple: do those cash assumptions feel realistic enough to anchor your own view of value, or too rich for comfort?

To unpack how those inputs feed into the cash flow result and stress test the moving parts in your own way, Look into how the SWS DCF model arrives at its fair value.

Next Steps

Sentiment around Solvay is mixed, which is exactly when independent thinking matters most. Move quickly, review the data first hand, and weigh both the 2 key rewards and 4 important warning signs

Looking for more investment ideas beyond Solvay?

If you stop with Solvay, you miss the chance to compare it against other opportunities that might fit your goals even better.

Use these focused screens on Simply Wall St to pressure test your thinking and surface fresh ideas fast.

• Target resilient cash generators by reviewing our 215 dividend fortresses that concentrate income potential with higher yielding payouts and stronger financial backing.
• Hunt for quality at a discount through the 592 high quality undiscovered gems that highlight solid fundamentals where wider attention has not yet fully arrived.
• Reduce portfolio gut checks by scanning the 215 resilient stocks with low risk scores that filter for sturdier balance sheets and more measured risk profiles before trouble shows up.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com